2024-11-18 04:36:33
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Corporate/ 2023-07-23
Innovent Announces NMPA Acceptance of a ...

SAN FRANCISCO and SUZHOU,China,Nov. 4,2021--Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that de...

Breakthrough for medtech pioneer: Syntellix receives product approval for India, opening up fast-growing market with 1.38 billion people
Health/ 2023-07-22
Breakthrough for medtech pioneer: Syntel...

Syntellix CEO Claassen: "Greatest and most important success in the company\'s history" -Indian CDSCO grants approvals for five MA...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release